PROVIDENCE — IBM Watson Health has named Rhode Island Hospital’s cardiovascular program among the top 50 in the United States, making it one of three in New England and the only one in Rhode Island to receive such a distinction.
The recognition was made in IBM Watson Health’s recent 50 Top Cardiovascular Hospitals 2018 study. The annual study, conducted by IBM Watson Health’s Truven Health Analytics, identifies the top U.S. hospitals for inpatient cardiovascular services. The study uses a balanced national scorecard of hospital performance metrics to identify the highest performing cardiovascular service lines in the nation.
The study measures attainment in key performance areas: risk-adjusted inpatient mortality, risk-adjusted complications, percentage of coronary bypass patients with internal mammary artery use, 30-day mortality rates, 30-day readmission rates, severity-adjusted average length of stay, wage- and severity-adjusted average cost per case and CMS 30-day episode payment measures. The study has been conducted annually since 1999. This is the fourth time Rhode Island Hospital has been recognized with this honor.
This study is part of the Watson Health 100 Top Hospitals program. Since 1993, the Watson Health 100 Top Hospitals program has used independent and objective research to guide hospital and health system performance.
“We are so honored that Rhode Island Hospital has been recognized by IBM Watson for our cardiac care. This speaks volumes to the tremendous expertise within the Lifespan Cardiovascular Institute, and the outstanding patient care provided in the inpatient setting at Rhode Island Hospital,” said Margaret M. Van Bree, president of Rhode Island Hospital.
Rob Borkowski is a PBN staff writer. Email him at Borkowski@PBN.com.
